Dr. StandaertThe explicitly translational nature of the new program was captured in its name, the Center for Neurodegeneration and Experimental Therapeutics, later renamed The Killion Center for Neurodegeneration and Experimental Therapeutics in April 2025. The center was officially chartered by the Board of Trustees in February, 2007.  In 2013, after Dr. Standaert had become chair of the neurology department, Dr. Erik Roberson and Dr. Andy West became co-directors of the Killion Center, and since 2018 Dr. Roberson has led the center.

Retreat 2020